What is the impact of lipid-lowering therapies on cardiovascular disease incidence among women with familial hypercholesterolaemia: A systematic review
LLTs are effective in reducing CVD risk in women with FH, yet treatment disparities persist. Addressing barriers such as adherence, hormonal influences and access to advanced therapies is essential. Personalised, gender-specific strategies are needed to close care gaps and improve outcomes for this high-risk population.
Authors
- Catherine Hennessy (ORCID: https://orcid.org/0009-0007-1498-4767)
- Linda Nugent
- Zena E. H. Moore (ORCID: https://orcid.org/0000-0002-4692-9718)
- Tom O’Connor (ORCID: https://orcid.org/0000-0001-5948-0975)
- Declan Patton (ORCID: https://orcid.org/0000-0003-1018-2605)
- Chanel Watson (ORCID: https://orcid.org/0000-0002-8548-1813)
Institutions
- Royal College of Surgeons in Ireland (IE)
Publication Details
- Journal
- Women s Health
- Published
- 2025-05-01
- DOI
- https://doi.org/10.1177/17455057251392356
- Primary Topic
- Menopause: Health Impacts and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00